Source link : https://newshealth.biz/health-news/amid-safety-investigation-attr-gene-therapy-buoyed-by-good-3-year-data/
(MedPage Today) — NEW ORLEANS — Despite ongoing scrutiny about its safety, nexiguran ziclumeran (nex-z) still had promising effectiveness data to hold onto. In an update on nex-z’s phase I study, the CRISPR-Cas9 gene therapy stayed the course… Source link : https://www.medpagetoday.com/meetingcoverage/aha/118460 Author : Publish date : 2025-11-12 15:00:00 Copyright for syndicated content belongs to […]
The post Amid Safety Investigation, ATTR Gene Therapy Buoyed by Good 3-Year Data first appeared on News Health.
—-
Author : News Health
Publish date : 2025-11-12 15:00:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8